MA42521A - Système d'administration transdermique - Google Patents

Système d'administration transdermique

Info

Publication number
MA42521A
MA42521A MA042521A MA42521A MA42521A MA 42521 A MA42521 A MA 42521A MA 042521 A MA042521 A MA 042521A MA 42521 A MA42521 A MA 42521A MA 42521 A MA42521 A MA 42521A
Authority
MA
Morocco
Prior art keywords
delivery system
transdermal delivery
transdermal
delivery
Prior art date
Application number
MA042521A
Other languages
English (en)
Inventor
Deborah Phyllis Harding
Helen Johnson
Gill Mundin
Kevin Smith
Steve Whitelock
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Publication of MA42521A publication Critical patent/MA42521A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
MA042521A 2015-07-30 2016-07-28 Système d'administration transdermique MA42521A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1513441.4A GB201513441D0 (en) 2015-07-30 2015-07-30 Transdermal delivery system

Publications (1)

Publication Number Publication Date
MA42521A true MA42521A (fr) 2018-06-06

Family

ID=54062902

Family Applications (1)

Application Number Title Priority Date Filing Date
MA042521A MA42521A (fr) 2015-07-30 2016-07-28 Système d'administration transdermique

Country Status (16)

Country Link
US (1) US20180221299A1 (fr)
EP (1) EP3328431A1 (fr)
JP (1) JP2018528175A (fr)
KR (1) KR20180035859A (fr)
CN (1) CN108025077A (fr)
AR (1) AR105533A1 (fr)
AU (1) AU2016298761A1 (fr)
BR (1) BR112018001615A2 (fr)
CA (1) CA2994103A1 (fr)
GB (1) GB201513441D0 (fr)
IL (1) IL256995A (fr)
MA (1) MA42521A (fr)
MX (1) MX2018001318A (fr)
SG (1) SG10201913254RA (fr)
TW (1) TW201713340A (fr)
WO (1) WO2017017452A1 (fr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10231248A (ja) * 1997-02-19 1998-09-02 T T S Gijutsu Kenkyusho:Kk ジヒドロエトルフィン含有経皮吸収型製剤
US6716449B2 (en) * 2000-02-08 2004-04-06 Euro-Celtique S.A. Controlled-release compositions containing opioid agonist and antagonist
TWI630208B (zh) * 2008-12-08 2018-07-21 歐陸斯迪公司 二氫羥戊甲嗎啡

Also Published As

Publication number Publication date
SG10201913254RA (en) 2020-03-30
WO2017017452A1 (fr) 2017-02-02
TW201713340A (zh) 2017-04-16
MX2018001318A (es) 2018-08-15
IL256995A (en) 2018-03-29
AU2016298761A1 (en) 2018-02-15
GB201513441D0 (en) 2015-09-16
KR20180035859A (ko) 2018-04-06
JP2018528175A (ja) 2018-09-27
AR105533A1 (es) 2017-10-11
CA2994103A1 (fr) 2017-02-02
CN108025077A (zh) 2018-05-11
EP3328431A1 (fr) 2018-06-06
US20180221299A1 (en) 2018-08-09
BR112018001615A2 (pt) 2018-09-18

Similar Documents

Publication Publication Date Title
DK3368108T3 (da) Medikamenttilførselsanordning
HK1247878A1 (zh) 藥物輸送裝置
HK1247875A1 (zh) 藥物輸送裝置
DK3204876T3 (da) Lægemiddelafgivelsesindretning
HK1248626A1 (zh) 藥物輸送裝置
DK3265421T3 (da) Doseringssystem
DK3171921T3 (da) Lægemiddelafgivelsesindretning
HK1246707A1 (zh) 藥物輸送裝置
DK3519018T3 (da) Medikamentadministrationsanordning
DK3099356T3 (da) Medikamentadministrationsanordning
DK3380146T3 (da) Medikamentadministrationsanordning
DK3310800T3 (da) Leveringssystem til styret lægemiddelfrigivelse
ES2982391T3 (es) Dispositivo médico de administración
DK3400045T3 (da) Medikamentadministrationsanordning
DK3380139T3 (da) Medikamentadministrationsanordning
DK3570911T3 (da) Medikamenttilførselsanordning
DK3250183T3 (da) Vaginal lægemiddeltilførselsanordning
DK3288955T3 (da) Bortezomib-baseret afgivelsessystem
DK3558423T3 (da) Medikamentadministrationsanordning
HUE057487T2 (hu) Gyógyszeradagoló rendszer
DK3496783T3 (da) Medikamentadministrationsanordning
DK3349825T3 (da) Lægemiddeladministrationsanordning
IL246874A0 (en) drug delivery system
IT201700043316A1 (it) Drug delivery system
DK3449892T3 (da) Lægemiddeludleveringsapparat